DIVERTEX Trademark

Trademark Overview

On Thursday, July 27, 2017, a trademark application was filed for DIVERTEX with the United States Patent and Trademark Office. The USPTO has given the DIVERTEX trademark a serial number of 87545864. The federal status of this trademark filing is REGISTERED as of Tuesday, December 4, 2018. This trademark is owned by Santen Pharmaceutical Co., Ltd.. The DIVERTEX trademark is filed in the Medical Instrument Products category with the following description:

Ophthalmic medical device, namely, glaucoma tube shunt; surgical apparatus and instruments for use in ophthalmic surgery; medical device for non-laser glaucoma surgery; ocular implants and devices; ocular implants and devices for use in treating glaucoma; ocular implants and devices, namely, shunts, stents, ophthalmic cutting instruments, shunt and stent applicators, and vision screening instruments, for use in treating glaucoma
divertex

General Information

Serial Number87545864
Word MarkDIVERTEX
Filing DateThursday, July 27, 2017
Status700 - REGISTERED
Status DateTuesday, December 4, 2018
Registration Number5620106
Registration DateTuesday, December 4, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements

Goods and ServicesOphthalmic medical device, namely, glaucoma tube shunt; surgical apparatus and instruments for use in ophthalmic surgery; medical device for non-laser glaucoma surgery; ocular implants and devices; ocular implants and devices for use in treating glaucoma; ocular implants and devices, namely, shunts, stents, ophthalmic cutting instruments, shunt and stent applicators, and vision screening instruments, for use in treating glaucoma

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, August 1, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanten Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 530-8552
JP
Party NameSanten Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 533-8651
JP
Party NameSanten Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 533-8651
JP

Trademark Events

Event DateEvent Description
Monday, December 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 4, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, November 1, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, October 9, 2018NOTICE OF ALLOWANCE CANCELLED
Thursday, November 1, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 9, 2018TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, October 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 14, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 21, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 13, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 4, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, June 4, 2018INQUIRY TO SUSPENSION E-MAILED
Monday, June 4, 2018SUSPENSION INQUIRY WRITTEN
Friday, May 11, 2018SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, May 11, 2018ASSIGNED TO LIE
Wednesday, April 25, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 31, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 31, 2017LETTER OF SUSPENSION E-MAILED
Tuesday, October 31, 2017SUSPENSION LETTER WRITTEN
Friday, October 27, 2017ASSIGNED TO EXAMINER
Tuesday, August 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 31, 2017NEW APPLICATION ENTERED

Related Keywords

divertex glaucoma instruments devices ophthalmic ocular implants surgery shunt medical device